Donna Ryan

10PUBLICATIONS
25CO-AUTHORS
Biomolecular modelling and designCardiology (incl. cardiovascular diseases)Nutrigenomics and personalised nutritionHaematologyFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 23, 2026
Semaglutide and cardiovascular risk reduction: a mediation analysis of the SELECT trial.

|Aug 18, 2026
Effect of Semaglutide on the Inflammatory Biomarker High-Sensitivity CRP in Patients With Established Cardiovascular Disease and Overweight or Obesity in SELECT: A Prespecified Secondary Analysis.

|May 04, 2025
New drugs for the treatment of obesity: do we need approaches to preserve muscle mass?

Donna H Ryan

|Jun 22, 2024
Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT.

Ildiko Lingvay, John Deanfield, Steven E Kahn

|Mar 25, 2022
Beyond appetite regulation: Targeting energy expenditure, fat oxidation, and lean mass preservation for sustainable weight loss.

Berit Østergaard Christoffersen, Guillermo Sanchez-Delgado, Linu Mary John

|Feb 08, 2022
The energy balance model of obesity: beyond calories in, calories out.

Kevin D Hall, I Sadaf Farooqi, Jeffery M Friedman

Pageof 2

Frequent Collaborators

3 joint publications

Ildiko Lingvay

2 joint publications

Eric Ravussin

2 joint publications

Helen M Colhoun

2 joint publications

Michael Lehrke